SCARLATA, GIUSEPPE GUIDO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 701
AS - Asia 674
EU - Europa 285
SA - Sud America 219
AF - Africa 31
Totale 1.910
Nazione #
US - Stati Uniti d'America 677
SG - Singapore 266
BR - Brasile 166
CN - Cina 132
IT - Italia 130
VN - Vietnam 128
IN - India 56
DE - Germania 48
HK - Hong Kong 25
NL - Olanda 20
RU - Federazione Russa 19
FI - Finlandia 16
AR - Argentina 15
EC - Ecuador 14
GB - Regno Unito 14
MX - Messico 12
ID - Indonesia 11
ZA - Sudafrica 10
AT - Austria 9
BD - Bangladesh 9
CA - Canada 8
FR - Francia 8
IQ - Iraq 7
SE - Svezia 7
IL - Israele 5
PE - Perù 5
PK - Pakistan 5
PY - Paraguay 5
TR - Turchia 5
CL - Cile 4
MA - Marocco 4
BG - Bulgaria 3
CO - Colombia 3
DZ - Algeria 3
JP - Giappone 3
KE - Kenya 3
PH - Filippine 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BO - Bolivia 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
JO - Giordania 2
NG - Nigeria 2
SN - Senegal 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
ES - Italia 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UA - Ucraina 1
ZM - Zambia 1
Totale 1.910
Città #
Dallas 196
San Jose 192
Singapore 103
Ashburn 81
Santa Clara 54
Ho Chi Minh City 48
Bengaluru 39
Hefei 38
Beijing 31
Munich 30
Hanoi 26
Hong Kong 25
São Paulo 24
Chicago 15
Turku 11
Los Angeles 8
Milan 8
New York 8
Catania 7
London 7
Rio de Janeiro 7
Belo Horizonte 6
Florence 6
Kiel 6
San Nicola Manfredi 6
St Louis 6
Amsterdam 5
Bari 5
Brasília 5
Hangzhou 5
Helsinki 5
Palermo 5
Porto Alegre 5
Rome 5
Stockholm 5
Taranto 5
Thái Bình 5
Vienna 5
Assago 4
Biên Hòa 4
Chennai 4
Da Nang 4
Guayaquil 4
Haiphong 4
Johannesburg 4
Nuremberg 4
Potenza 4
San Francisco 4
Baghdad 3
Boardman 3
Boydton 3
Brooklyn 3
Campinas 3
Cosenza 3
Curitiba 3
Dhaka 3
Elk Grove Village 3
Lima 3
Lấp Vò 3
Manassas 3
Mexico City 3
Moscow 3
Mumbai 3
Santiago 3
Santo André 3
Shanghai 3
St Petersburg 3
Tashkent 3
Tokyo 3
Turin 3
Addis Ababa 2
Ankara 2
Asunción 2
Atlanta 2
Avellaneda 2
Bagnara Calabra 2
Baku 2
Bauru 2
Blumenau 2
Bogotá 2
Bologna 2
Boston 2
Campo Grande 2
Cao Lanh 2
Caxias do Sul 2
Council Bluffs 2
Criciúma 2
Dakar 2
Fermo 2
Gatchina 2
Guarulhos 2
Ha Long 2
Hacienda Ibarra 2
Honolulu 2
Hortolândia 2
Ibarra 2
Lagos 2
Manchester 2
Marrakesh 2
Montreal 2
Totale 1.214
Nome #
Combined Model for the Diagnosis of Hepatocellular Carcinoma: A Pilot Study Comparing the Liver to Spleen Volume Ratio and Liver Vein to Cava Attenuation 193
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 96
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? 66
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 66
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 63
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 61
Gastrointestinal symptoms, dietary regimen and anxiety levels during the COVID-19 pandemic among medical students: results from a web-based survey 57
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 53
The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review 50
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 49
The levels of inflammatory, angiogenic, and stress biomarkers in plasma of donors depending on anti-SARS-CoV-2 IgG titers 49
Portal hypertension-associated gastric pathology: role of endoscopic banding ligation 48
Preventive and Therapeutic Effects of Baicalein, Galangin, and Isorhamnetin in Chronic Liver Diseases: A Narrative Review 46
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients 44
Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease 43
Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease 43
Orthopedic Device-Related Infections Due to Emerging Pathogens Diagnosed by a Combination of Microbiological Approaches: Case Series and Literature Review 42
Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series 42
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 42
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 41
Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience 41
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 40
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 40
Comment on Meneghini et al. The Impact of Nutritional Therapy in the Management of Overweight/Obese PCOS Patient Candidates for IVF. Nutrients 2023, 15, 4444 39
Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital 39
Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review 39
Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma 37
Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition 37
Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study 36
Is the Mediterranean diet a good preventive measure for NASH? 33
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease 32
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 31
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease 31
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 29
Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection 29
Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway? 26
Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors 26
Should Routine Diagnostics Implement Gut Microbiota Analysis? 25
Gender, Age, Alpha-fetoprotein, and Des-gamma-carboxyprothrombin Score as a Novel Approach to Early Detection of Hepatocellular Carcinoma: A Narrative Review 21
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features 20
Functional disorders of the upper digestive tract: epidemiological, clinical and therapeutic aspects 19
Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance 19
Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288 15
Apolipoproteins Levels in Fatty Liver Disease: A Systematic Review and Meta-analysis 15
Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis 15
Annurca Apple Extract and Colorectal Cancer Prevention: Preliminary In Silico Evaluation of Chlorogenic Acid 11
Gut microbiota: origin or panacea for all ills? Gut microbiota and systemic diseases 11
The Mediterranean diet: historical benefits and contemporary challenges in Southern Italy 11
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Patient with Phelan–McDermid Syndrome 9
Irritable bowel syndrome after Clostridioides difficile infection 8
The role of gut microbiota in the pathogenesis of primary biliary cholangitis: an immunological perspective 6
Totale 1.984
Categoria #
all - tutte 11.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202311 0 0 0 0 0 0 8 0 0 1 0 2
2023/202476 12 3 7 7 3 5 6 10 5 0 4 14
2024/2025415 28 7 23 14 43 64 16 20 17 7 67 109
2025/20261.482 61 192 249 196 128 86 174 71 160 112 39 14
Totale 1.984